PG Procter & Gamble Co. featured news, full reports, and detailed charts
Procter & Gamble Co. (PG) Wrap Up:
The Procter & Gamble Company engages in the manufacture and sale of consumer goods worldwide. The company operates in three global business units (GBUs): Beauty, Health and Well-Being, and Household Care. The Beauty GBU offers cosmetics, deodorants, fragrances, hair care products, and personal cleansing and skin care products under the Head & Shoulders, Olay, Pantene, and Wella brands; and blades and razors, electric hair removal devices, face and shave products, and home appliances under the Braun, Fusion, Gillette, and Mach3 brands. The Health and Well-Being GBU provides feminine care, oral care, and personal health care products under Always, Crest, and Oral-B brands; and pet food and snacks under the Iams and Pringles brands. The Household Care GBU offers air care products, batteries, dish care products, and fabric care and surface care products under the Ariel, Dawn, Downy, Duracell, Gain, and Tide brands; and baby wipes, bath tissues, diapers, facial tissues, and paper towels under the Bounty, Charmin, and Pampers brands. The company offers its products to mass merchandisers, grocery stores, membership club stores, and drug stores. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.Procter & Gamble Co. (PG:NYSE)
Snapshot of Procter & Gamble Co. (PG)
|
OPEN
$62.00
|
PREVIOUS CLOSE
$62.15
|
||
|
DAY HIGH
$62.22
|
DAY LOW
$61.48
|
||
|
52 WEEK HIGH
11/25/08 - $65.45
|
52 WEEK LOW
03/9/09 - $43.93
|
||
|
MARKET CAP
180.6B
|
AVERAGE VOLUME 3 mo
12.7M
|
||
|
DILUTED EPS TTM
$3.54
|
SHARES OUTSTANDING
2.9B
|
||
|
EX-DATE
10/21/09
|
P/E TTM
17.5x
|
||
|
DIVIDEND
$1.76
|
DIVIDEND YIELD
2.85%
|
||
| K = Thousands M = Millions B = Billions | |||
| > | |||
related news
If approved, the deal will give the search engine a big head start in cell-phone advertising
Setting tradition aside, the 95-year-old insurance company looked to Apple and American Girl as a guide to its future
Setting tradition aside, the 95-year-old insurance company looked to Apple and American Girl as a guide to its future
At GE, P&G, and other companies, a design perspective is a problem-solving apparatus that can be applied companywide
related news
PG Top Compensated Officers
Executives, Board Directors
Key developments for Procter & Gamble Co. (PG)
Procter & Gamble Co. - Conference Presentation Calls
The Wall Street Journal reported on November 17, 2009 that, S. C. Johnson & Son, Inc. has emerged as a bidder for Sara Lee Corp.'s air freshener operations. Reuters added that S.C. Johnson and Sara Lee declined to comment. Sara Lee had previously mandated Goldman Sachs to run an auction for its household-care business, which includes Kiwi shoe polish and insecticides. Sources had previously told Reuters that, Procter & Gamble Co. has already eyed the air freshener business, but does not want the other parts of the unit. The Wall Street report added that S. C. Johnson may be interested in the entire unit, which could be worth more than $700 million. A deal for the unit could still be weeks away, Wall Street said.
Parker Waichman Alonso LLP announces that they have filed a lawsuit against GlaxoSmithKline plc and Procter & Gamble Co. on behalf of an Nebraska woman who was diagnosed with neuropathy attributed to the use of Super PoliGrip(R) and Fixodent(R) denture adhesive creams. According to complaint, Jennifer J. Cornett, 61, received dentures approximately 9 years ago, and has used Super PoliGrip(R) and Fixodent(R). Ms. Cornett stopped using the denture adhesive creams after she was diagnosed with neuropathy attributed to excess zinc and copper depletion attributable to Super PoliGrip(R) and Fixodent(R). Her lawsuit alleges that Ms. Cornett now suffers from profound and permanent neurological injuries, which have left her unable to perform her normal, customary, and daily activities. The lawsuit maintains that Super PoliGrip(R) and Fixodent(R) contain a form of zinc, which is bonded to an unknown formulation. A small amount of zinc is necessary for a balanced diet. However, being exposed to an excessive amount of zinc can result in copper depletion and serious negative adverse neurological effects. In August 2008, the peer reviewed journal 'Neurology' reported on four patients suffering from neuropathy and other neurological symptoms typical of zinc poisoning and copper depletion. It was determined that excess use of denture cream could have been responsible for their symptoms. The complaint further alleges that the defendants failed to warn about their products' risks and failed to provide adequate warnings about the zinc in Super PoliGrip(R) and Fixodent(R), or adequate instructions to prevent deviation from accepted use. According to the lawsuit, had the defendants properly disclosed the risks associated with Super PoliGrip(R) and Fixodent(R), Ms. Cornett would never have used the products. Ms. Cornett's lawsuit names GlaxoSmithKline, the maker of Super PoliGrip(R), and Procter and Gamble Manufacturing Corp., the maker of Fixodent(R), as well as their subsidiaries, as defendants. This lawsuit is the latest of many filed by Parker Waichman Alonso LLP on behalf of the victims of zinc-containing denture adhesive creams. Ms. Cornett's lawsuit, along with dozens of others filed before it, has been consolidated for centralized and coordinated pre-trial proceedings in the Denture Cream Products Liability Litigation in the United States District Court for the Southern District of Florida, Miami Division, before the Honorable Judge Cecilia Altonaga (MDL No. 2051). Andres F. Alonso Esq., a partner with Parker Waichman Alonso LLP, was appointed Co-Lead Counsel to the Plaintiffs' Steering Committee in the litigation by Judge Altonaga in an order filed on July 13, 2009. On October 22, 2009, Mr. Alonso attended the most recent case management conference in the Denture Cream Products Liability Litigation.
PG Competitors
| Company | Last | Change |
| Johnson and Johnson | $62.31 USD | +0.37 |
| Kroger Co | $22.86 USD | +0.04 |
| Pfizer Inc | $18.36 USD | +0.25 |
| Unilever | €20.72 EUR | +0.055 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | PG | Industry Range |
| Price/Earnings | 17.6x |
|
| Price/Sales | 2.3x |
|
| Price/Book | 2.8x |
|
| Price/Cash Flow | 13.6x |
|
| TEV/Sales | 1.8x |
|
|
PG |
||
PG transactions
| Type Date |
Target |
|
Merger/Acquisition
August 24, 2009 |
Procter & Gamble Pharmaceuticals, Inc. |
|
Merger/Acquisition
August 10, 2009 |
Iams Pet Imaging, LLC |
|
Merger/Acquisition
June 16, 2009 |
ZIRH Holdings, LLC |
More Recent News About Procter & Gamble Co.
More news for PG
S.C. Johnson Joins Sara Lee Bidding
Personal Finance - Investing - Financial News - Business News - Stock Market Quotes & News - Small Business Advertise with us | Jobs at FOX Business Network | Internships at FBN Terms of use. Privacy Statement. For FOXBusiness.com technical issues write to foxbusinessonline@foxbusiness.com; for all other feedback, write to feedback@foxbusiness.com. Quotes delayed at least 15 minutes. Market Data provided by Interactive Data (Terms & Conditions). Powered and implemented by Interactive Data Managed Solutions. Company fundamental data provided by Morningstar. Earnings estimates data provided by Zacks. Mutual fund data provided by Lipper. Economic data provided by Econoday. Dow Jones & Company Terms & Conditions. This material may not be published, broadcast, rewritten, or redistributed. ©2009 FOX News Network, LLC. All rights reserved. ...Click here to read the whole Article (external link)
WSJ: S.C. Johnson challenges P&G for Sara Lee unit
ONLINE: home | business news | small business | sales & marketing | real estate | events | community | careers | city guide | advertise | about us | rss PRINT: subscribe | renew | advertise | book of lists | business intelligence | classifieds | ...Click here to read the whole Article (external link)
[$$] S.C. Johnson Vies With P&G For Sara Lee Unit
Answers allows you to tap the knowledge of Community members. Answer a question below or ask a question. Q: How did North Korea acquire the know-how to develop nuclear weapons and who are the scientists and engineers who are carrying out the research (foreign or domestic)? Please fill out the answer field. The language you used does not comply with community standards. Please re-enter. ...Click here to read the whole Article (external link)
Report: S.C. Johnson may be eyeing Sara Lee unit
Copyright © 2009 Yahoo! All rights reserved. Privacy Policy - Terms of Service - Copyright Policy - Report Problems Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quote data delayed 15 minutes for Nasdaq, NYSE and Amex. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Yahoo! is not an investment adviser and does not provide, endorse or review any information or data contained herein....Click here to read the whole Article (external link)
FDA Says Heartburn Drugs Can Interfere With Plavix
By ALICIA MUNDY and JARED A. FAVOLE The Food and Drug Administration said Tuesday doctors should avoid using popular heartburn drugs such as Prilosec in combination with the anticlotting medicine Plavix, after studies showed the combination may blunt the effect of Plavix and increase patients' risk of heart attacks. The makers of Plavix, Bristol-Myers Squibb Co. and Sanofi-Aventis SA, updated Plavix's label to warn against the combination use. Plavix, which has annual world-wide sales of more than $8 billion, is commonly used to prevent clots in patients with artery-opening stents or those who have had a heart attack or stroke. About half of patients taking Plavix also take Nexium, Prilosec or a similar medicine to prevent stomach bleeding and ulcers, frequent side effects of Plavix. Nexium is made by AstraZeneca PLC, while Procter & Gamble Co. sells an over-the-counter version of Prilosec called Prilosec OTC. A spokesman for AstraZeneca said the company is examining the FDA warning and "believes that research needs to continue into the concomitant use of these types of medicines." A Procter & Gamble spokeswoman said the company is evaluating whether a label change on Prilosec OTC is necessary. Sanofi said it updated its label after conducting two studies with Bristol-Myers that underscored the potential interactions a...Click here to read the whole Article (external link)
